InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Explore the detailed record of transactions filed by Dexcel Pharma Technologies Ltd.. Officer active across 2 companies, notably Protalix BioTherapeutics, Inc.. In total, 3 reports have been recorded. Total volume traded: €368k. The latest transaction was disclosed on 22 April 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
€111,96731,685 shares@ €3.53380.0005% mcap100.0% of flow
Common Shares
SEC:0001104659-22-049930:0·
Ideal exit: 17 Jan 2023 (T+270)
€128,21961,211 shares@ €2.0947100.0% of flow
Common Stock
SEC:0001104659-21-076488·
€128,21961,211 shares@ €2.09470.080% mcap50.0% of flow
Common Stock
SEC:0001104659-21-076488:0·
3 of 3 declarations
